Clinical Trial Update: A Phase II Trial of Lapatinib (TYKERB) + Pemetrexed (ALIMTA) in Advanced Non Small Cell Lung Cancer With an Initial Dose Finding Phase [Phase 1]

View source ↗

Summary

Phase II trial of lapatinib (TYKERB) plus pemetrexed (ALIMTA) in advanced non-small cell lung cancer has completed. The study included an initial dose-finding P…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Alimta (pemetrexed)
• Tykerb (lapatinib)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Lung Cancer, Non-Small Cell | Phase 1 | Status: COMPLETED